NCT04905979View on ClinicalTrials.gov

Trial of AD113 and Atomoxetine in OSA Patients With Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2021

Primary Completion Date

January 31, 2023

Study Completion Date

May 31, 2023

Conditions
Obstructive Sleep ApneaHypertension
Interventions
DRUG

AD113

Two oral capsules administered before bed

DRUG

Atomoxetine

Two oral capsules administered before bed

Trial Locations (3)

21286

PCCAB, Towson

29201

Bogan Sleep Consultants, Columbia

45245

Intrepid Research, Cincinnati

Sponsors

Lead Sponsor

Apnimed
All Listed Sponsors
lead

Apnimed

INDUSTRY

NCT04905979 - Trial of AD113 and Atomoxetine in OSA Patients With Hypertension | Biotech Hunter | Biotech Hunter